Human C-reactive protein gene polymorphism and metabolic syndrome are associated with premature coronary artery disease

Gene

Volumn 532, Issue 2, 2013, Pages 216-221

  Abd El Aziz, Tarek A ^a   Mohamed, Rasha H ^b  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b Zagazig University   (Egypt)

Author keywords

CRP gene; Hs CRP; Metabolic syndrome; Polymorphism; Premature CAD

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DNA POLYMORPHISM; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HETEROZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; POLYMERASE CHAIN REACTION; PREMATURE CORONARY ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

C-REACTIVE PROTEIN; CAD; CORONARY ARTERY DISEASE; CRP; CRP GENE; ELISA; HDLC; HIGH-DENSITY LIPOPROTEIN CHOLESTEROL; HIGH-SENSITIVITY C-REACTIVE PROTEIN; HIGH-SENSITIVITY ENZYME-LINKED IMMUNOSORBENT ASSAY; HS-CRP; LDLC; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METABOLIC SYNDROME; METS; PCAD; POLYMORPHISM; PREMATURE CAD; PREMATURE CORONARY ARTERY DISEASE; SINGLE NUCLEOTIDE POLYMORPHISMS; SNPS; TC; TG; TNF-Α; TOTAL CHOLESTEROL; TRIGLYCERIDES; TUMOR NECROTIZING FACTOR-Α;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; EGYPT; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84886749767     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.042     Document Type: Article

References (29)

1. Abdel-Aziz T.A., Mohamed R.H. Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease. Mol. Biol. Rep. 2013, 40:3065-3071.
2. Assman S.F., Hosmer D.W., Lemeshow S., Mundt K.A. Confidence intervals for measures of interaction. Epidemiology 1996, 7:286-290.
3. Cao H., Hegele R.A. Human C-reactive protein (CRP) 1059G/C polymorphism. J. Hum. Genet. 2000, 45:100-101.
4. Carlson C.S., et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet. 2005, 77:64-77.
5. Dai D.F., et al. Human C-reactive protein (CRP) Gene 1059 G>C polymorphism is associated with plasma CRP concentration in patients receiving coronary angiography. J. Formos. Med. Assoc. 2007, 106:347-354.
6. De Ferranti S.D., et al. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004, 110:2494-2497.
7. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
8. Festa A., D'Agostino R., Howard G., Mykkänen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as a part of the insulin resistance syndrome. Circulation 2000, 102:42-53.
9. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18:499-502.
10. Gordon D., Haynes C., Blumenfeld J., Finch S.J. PAWE-3D: visualizing power for association with error in case/control genetic studies of complex traits. Bioinformatics 2005, 21:3935-3937.
11. Grassi G., Arenare F., Quarti-Trevano F., Seravalle G., Mancia G. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Prog. Cardiovasc. Dis. 2009, 52:31-37.
12. Haffner S.M. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 2006, 97:3A-11A.
13. Hingorani A.D., Shah T., Casas J.P. Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk. Eur. Heart J. 2006, 27:1261-1263.
14. Ikonomova K. Inflammation and metabolic syndrome. Turk. J. Endocrinol. Metab. 2004, 3:85-89.
15. Iribarren C., et al. Metabolic syndrome and early-onset coronary artery disease is the whole greater than its parts?. J. Am. Coll. Cardiol. 2006, 48:1800-1807.
16. Kampoli A.M., Tousoulis D., Antoniades C., Siasos G., Stefanadis C. Biomarkers of premature atherosclerosis. Trends Mol. Med. 2009, 15:323-332.
17. Kovacs A., et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 2005, 178:193-198.
18. Montecucco F., Mach F. New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor. Clin. Interv. Aging 2008, 3:341-349.
19. Pankow J.S., et al. Familial and ge-netic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 2001, 154:681-689.
20. Pearson T.A., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499-511.
21. Song Q., Wang S.S., Zafari A.M. Genetics of the metabolic syndrome. Hosp. Physician 2006, 10:51-61.
22. Speidl W.S., et al. High-sensitivity C-reactive protein in the prediction of coronary events in patients with premature coronary artery disease. Am. Heart J. 2002, 144:449-455.
23. Suk H.J., Ridker P.M., Cook N.R., Zee R.Y. Relation of polymor-phism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 2005, 178:139-145.
24. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999, 282:2131-2135.
25. Wu T.L., et al. Development of ELISA on microplate for serum C-reactive protein and establishment of age-dependent normal reference range. Clin. Chim. Acta 2002, 322:163-168.
26. Xu H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112:1821-1830.
27. Zebrack J.S., Muhlestein J.B., Horne B.D., Anderson J.L. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina FREE. J. Am. Coll. Cardiol. 2002, 39:632-637.
28. Zee R.Y., Ridker P.M. Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002, 162:217-219.
29. Zee R.Y., Hegener H.H., Fernandez-Cruz A., Lindpaintner K. C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosis. Atherosclerosis 2004, 176:393-396.